ADHD
253 results
101 - 200
Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults
Sleep counseling improves sleep and symptoms in children with ADHD- Digital media use associated with ADHD symptom development among adolescents
- ADHD: A lot of research, not a lot of guidance
- Bupropion for attention deficit hyperactivity disorder (ADHD) in adults
Cognitive‐behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults - Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents
- 2019 guidelines for ADHD: structure plus medication
- A restriction diet will benefit some children with ADHD
- Extended‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
- St. John's wort not effective for treatment of ADHD
- Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents
- Guanfacine effective for ADHD but side effects are significant
- Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders
- Higher risk of psychosis with amphetamines than methylphenidate in treatment of ADHD
- Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents
- Cognitive‐behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults
- Immediate‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
- ADHD drugs do not increase serious CV events in children and young adults
- Acupuncture for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents: Cochrane systematic review
- Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
- Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents: Cochrane systematic review
- Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults: Cochrane systematic review
- No increased risk of ASD, ADHD, or SGA with first-trimester antidepressant use
- Acetaminophen use during pregnancy is not associated with risk of autism, ADHD, or intellectual disability
- Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years
- Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years: Cochrane systematic review
- Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non‐randomised studies
- Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non-randomised studies: Cochrane systematic review
- Stimulant and non‐stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy
- Risperidone for attention‐deficit hyperactivity disorder in people with intellectual disabilities
- Amfetamine for attention deficit hyperactivity disorder in people with intellectual disabilities
- Maternal triptan use during pregnancy is not associated with risk of attention-deficit/hyperactivity disorder in offspring
- Learning disorders
- Family therapy for attention‐deficit disorder or attention‐deficit/hyperactivity disorder in children and adolescents
- Atomoxetine better than placebo but not uniformly effective in young children
- Prescription stimulant use during pregnancy is unlikely to harm offspring
- No association between stimulant treatment for attention-deficit/hyperactivity disorder and substance use
- Treatments for attention-deficit/hyperactivity disorder
- Psychopharmacotherapy in children and adolescents
- Prenatal cannabis exposure is not associated with an increased incidence of several neuropsychiatric disorders
- Obsessive-compulsive disorder (OCD)